Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-02T22:40:46.828Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluating the utility of routine screening catheterisation before interstage discharge of infants with single-ventricle physiology

Published online by Cambridge University Press:  30 May 2019

Katherine E. Bates ,
Andrew C. Glatz ,
Therese M. Giglia ,
Shobha S. Natarajan ,
Chitra Ravishankar ,
Alyson Stagg  and
Jonathan J. Rome
Katherine E. Bates*
Affiliation:
Department of Pediatrics and Communicable Diseases, Congenital Heart Center, C.S. Mott Children’s Hospital, Ann Arbor, MI, USA
Andrew C. Glatz
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Therese M. Giglia
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Shobha S. Natarajan
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Chitra Ravishankar
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Alyson Stagg
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Jonathan J. Rome
Affiliation:
Department of Pediatrics, Cardiac Center, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
*
Author for correspondence: Katherine E. Bates, MD, MS, Congenital Heart Center, C.S. Mott Children’s Hospital, University of Michigan Medical School, 1540 E. Hospital Drive, Ann Arbor, MI 48109-4204, USA. Tel: 734-232-8426; Fax: 734-936-4628; E-mail: kebates@med.umich.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Interstage mortality causes are often unknown in infants with shunt-dependent univentricular defects. For 2 years, screening catheterisation was encouraged before neonatal discharge to determine if routine evaluation improved interstage outcomes.

Methods:

Retrospective single-centre review of home monitoring programme from December, 2010 to June, 2012. Composite scores were created for physical examination/echocardiography risk factors; catheterisation risk factors; and interstage adverse events. Composite scores were compared between usual care and screening catheterisation groups. The ability of each risk factor composite to predict interstage adverse events, individually and in combination, was assessed with sensitivity, specificity, and receiver operating characteristic curves.

Results:

There were 27 usual care and 32 screening catheterisation patients. There were no significant differences between groups except rates of catheterisation before discharge (29.6 versus 100%, p < 0.001). Usual care patients who underwent catheterisation for clinical indications had higher intervention rates (37.5 versus 3.1%, p = 0.004). Physical examination/echocardiography risk factor frequency was similar, but usual care patients with catheterisation had a higher catheterisation risk factor frequency. Interstage adverse event frequency was similar (48.2 versus 53.1%, p = 0.7). For interstage adverse event prediction, sensitivity for the physical examination/echocardiography, catheterisation, and either risk factor composites was 53.3, 72, and 80%, respectively; specificity was 59, 60, and 48%. The area under the receiver operating characteristic curve was 0.56, 0.66, and 0.64.

Conclusion:

Screening catheterisation evaluation offered slightly increased sensitivity and specificity, but no difference in interstage adverse event frequency. Given this small advantage versus known risks, screening catheterisations are no longer encouraged.

Keywords

CHDhypoplastic left heart syndromeNorwood procedurecatheterization
Type
Original Article
Information
Cardiology in the Young , Volume 29 , Issue 5 , May 2019 , pp. 660 - 666
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ohye, RG, Sleeper, LA, Mahony, L, et al. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010; 362: 1980–1992. doi: 10.1056/NEJMoa0912461.CrossRefGoogle ScholarPubMed
Ghanayem, NS, Hoffman, GM, Mussatto, KA, et al. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 2003; 126: 1367–1375. doi: 10.1016/S0022-5223(03)00071-0.CrossRefGoogle ScholarPubMed
Dobrolet, NC, Nieves, JA, Welch, EM, et al. New approach to interstage care for palliated high-risk patients with congenital heart disease. J Thorac Cardiovasc Surg 2011; 142: 855–860. doi: 10.1016/j.jtcvs.2011.01.054.CrossRefGoogle ScholarPubMed
Hansen, JH, Furck, AK, Petko, C, et al. Use of surveillance criteria reduces interstage mortality after the Norwood operation for hypoplastic left heart syndrome. European Journal of Cardio-Thoracic Surgery. 2012; 41: 1013–1018. doi: 10.1093/ejcts/ezr190.CrossRefGoogle ScholarPubMed
Petit, CJ, Fraser, CD, Mattamal, R, Slesnick, TC, Cephus, CE, Ocampo, EC. The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival. J Thorac Cardiovasc Surg 2011; 142: 1358–1366. doi: 10.1016/j.jtcvs.2011.04.043.CrossRefGoogle ScholarPubMed
Anderson, JB, Beekman, RH, Kugler, JD, et al. Improvement in interstage survival in a national pediatric cardiology learning network. Circulation 2015; 8: 428–436. doi: 10.1161/CIRCOUTCOMES.115.001956.Google Scholar
Hehir, DA, Dominguez, TE, Ballweg, JA, et al. Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg 2008; 136: 94–99.e3. doi: 10.1016/j.jtcvs.2007.12.012.CrossRefGoogle ScholarPubMed
Ghanayem, NS, Allen, KR, Tabbutt, S, et al. Interstage mortality after the Norwood procedure: results of the multicenter Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg 2012; 144: 896–906. doi: 10.1016/j.jtcvs.2012.05.020.CrossRefGoogle ScholarPubMed
Hill, KD, Rhodes, JF, Aiyagari, R, et al. Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation 2013; 128: 954–961. doi: 10.1161/CIRCULATIONAHA.112.000488.CrossRefGoogle Scholar
Wellen, SL, Glatz, AC, Gillespie, MJ, Ravishankar, C, Cohen, MS. Usefulness of transthoracic echocardiography to accurately diagnose recoarctation of the aorta after the Norwood procedure. Am J Cardiol 2014; 114: 117–121. doi: 10.1016/j.amjcard.2014.04.014.CrossRefGoogle ScholarPubMed
Brown, DW, Gauvreau, K, Powell, AJ, et al. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional Glenn anastomosis in infants with functional single ventricle: a prospective randomized trial. Circulation 2007; 116: 2718–2725. doi: 10.1161/CIRCULATIONAHA.107.723213.CrossRefGoogle ScholarPubMed
Goldstein, BH, Holzer, RJ, Trucco, SM, et al. Practice variation in single-ventricle patients undergoing elective cardiac catheterization: a report from the congenital cardiac catheterization project on outcomes (C3PO). Congenit Heart Dis 2016; 11: 122–135. doi: 10.1111/chd.12299.CrossRefGoogle Scholar
Kugler, JD, Beekman, RH III, Rosenthal, GL, et al. Development of a pediatric cardiology quality improvement collaborative: from inception to implementation. From the Joint Council on Congenital Heart Disease Quality Improvement Task Force. Congenit Heart Dis 2009; 4: 318–328. doi: 10.1111/j.1747-0803.2009.00328.x.CrossRefGoogle ScholarPubMed